Postpartum thyroiditis (PPT) is an autoimmune destructive thyroiditis that occurs in some women during the postpartum period. Its immune perturbations have been partially worked out, but at the present time only TPOAb positivity is a reliable marker of this process. Groups at increased risk of developing PPT are well known. Nevertheless there is no consensus about screening for this disorder, which unfortunately causes considerable morbidity, at a physiologically, emotionally and socially vulnerable time. Nor are there effective strategies to prevent PPT in individuals at high risk. Treatment is empirical and largely symptomatic except in the hypothyroid phase when thyroxine may be required.
KeywordsPostpartum thyroiditis Postpartum Graves’ disease Risk factors Screening
- 1.De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543–65.CrossRefGoogle Scholar
- 8.Dhanoa L, Dresang LT. Should women be screened for postpartum hypothyroidism. Evid Based Pract. 2013;16:13.Google Scholar
- 9.Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W, American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011b;21:1081–125.CrossRefGoogle Scholar